Dr. Thota is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
UT Regional One Physicians, Inc
877 Jefferson Avenue
Memphis, TN 38103- Is this information wrong?
Education & Training
Cleveland Clinic FoundationFellowship, Hematology and Medical Oncology, 2013 - 2017
Osmania Medical College NTR UHSClass of 2007- Cleveland Clinic FoundationResidency, Internal Medicine
Certifications & Licensure
TN State Medical License 2020 - 2025
NY State Medical License 2017 - 2020
OH State Medical License 2010 - 2017- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Enasidenib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia With an IDH2 Gene Mutation Start of enrollment: 2019 Dec 02
Publications & Presentations
PubMed
- 15 citationsAcute Myeloid Leukemia, Version 3.2023, NCCN Clinical Practice Guidelines in Oncology.Daniel A Pollyea, Jessica K Altman, Rita Assi, Dale Bixby, Amir T Fathi, James M Foran, Ivana Gojo, Aric C Hall, Brian A Jonas, Ashwin Kishtagari, Jeffrey Lancet, Lori...> ;Journal of the National Comprehensive Cancer Network. 2023 May 1
- Safety and efficacy of CPX-351 in younger patients (<60 years old) with secondary acute myeloid leukemia.Amanda Przespolewski, Aaron D Goldberg, Chetasi Talati, Salman Fazal, Pankit Vachhani, Srinivasa R Sanikommu, Swapna Thota, Julian Waksal, Brian Ball, Christopher Famu...> ;Blood. 2023 Mar 23
- 44 citationsNCCN Guidelines® Insights: Myelodysplastic Syndromes, Version 3.2022.Peter L Greenberg, Richard M Stone, Aref Al-Kali, John M Bennett, Uma Borate, Andrew M Brunner, Wanxing Chai-Ho, Peter Curtin, Carlos M de Castro, H Joachim Deeg, Amy ...> ;Journal of the National Comprehensive Cancer Network. 2022 Feb 1
- Join now to see all
Abstracts/Posters
- Benefits of a Pharmacist Led Oral Chemotherapy Monitoring Program for Patients with Chronic Myeloid Malignancies: A Patient Reported Outcome (PRO) StudySwapna Thota, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- De Novo and Therapy-Related Acute Myeloid Leukemia and Myelodysplastic Syndrome: Similarities and Differences in SNP-Array Detected Chromosomal Aberrations in Pre-Tran...Swapna Thota, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Quantification of Humoral Immune Response to Influenza Vaccination in MDSSwapna Thota, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Join now to see all
Lectures
- Outcomes of AML Patients Treated with Gemtuzumab-Ozogamicin Based Therapies: A Cue to Optimal Chemotherapy Backbone61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Clinical Outcomes for Patients with Myeloid Malignancies Harboring IDH1/2mutations after Intensive Chemotherapy2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Press Mentions
Swapna Thota, MD, a Hematologist with Roswell Park Comprehensive Cancer CenterJune 11th, 2020- Targeted Drugs and Immunotherapies May Lower Risk of Therapy-Related Hematologic CancersMay 29th, 2020
Hospital Affiliations
St. Jude Children's Research HospitalMemphis, Tennessee
Regional One HealthMemphis, Tennessee
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
